Kaiser Permanente Washington researchers are exploring how to improve prevention and treatment of health issues due to alcohol and other drug use. The addictions research group conducts innovative research to help patients and their providers prevent and treat problems caused by alcohol, cannabis, opioids, and other drugs in health settings.
A major focus of the addictions research group is how to integrate patient-centered care for alcohol and other drug use into medical settings. For more than 3 decades, their work has focused on the need for health systems to routinely measure and address alcohol and other drug use as part of whole-person health, in nonjudgmental, patient-centered ways.
"Our alcohol-related research has built tools — such as a brief video, handout, and a patient decision aid — that help overcome stigma so that patients and families can find the help they want and need," said Katharine A. Bradley, MD, MPH, a senior investigator at Kaiser Permanente Washington Health Research Institute (KPWHRI) and internal medicine physician with Washington Permanente Medical Group.
The addictions research group is conducting a variety of studies to improve measures and documentation of substance use in the medical record. "We are working to find ways to easily document the extent of cannabis exposure for both medical and nonmedical use in electronic health records," said Gwen Lapham, PhD, MSW, a KPWHRI assistant investigator. Finding innovative ways to provide treatment is also a focus. "We are testing how to get proven online treatments for addiction into the hands of patients who could benefit," said Joseph E. Glass, PhD, MSW, a KPWHRI associate investigator whose research at the institute is funded in part by an early-career award to study the effectiveness of treatments for alcohol use disorders in primary care.
These are among the group’s current studies:
These are among the studies that the addictions research group has completed:
The SPARC trial successfully implemented behavioral health care into primary care. On our website, you can access tools for behavioral health integration, as well as frequently asked questions and publications.
Bagley SM, Chavez L, Braciszewski JM, Akolsile M, Boudreau DM, Lapham G, Campbell CI, Bart G, Yarborough BJH, Samet JH, Saxon AJ, Rossom RC, Binswanger IA, Murphy MT, Glass JE, Bradley KA. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems. Addict Sci Clin Pract. 2021;16(1):46. doi: 10.1186/s13722-021-00249-3. PubMed
Glass JE, Matson TE, Lim C, Hartzler AL, Kimbel K, Lee AK, Beatty T, Parrish R, Caldeiro RM, Garza McWethy A, Curran GM, Bradley KA. Approaches for implementing app-based digital treatments for drug use disorders into primary care: a qualitative, user-centered design study of patient perspectives. J Med Internet Res. 2021;23(7):e25866. doi: 10.2196/25866. PubMed
Matson TE, Carrell DS, Bobb JF, Cronkite DJ, Oliver MM, Luce C, Ghitza UE, Hsu CW, Campbell CI, Browne KC, Binswanger IA, Saxon AJ, Bradley KA, Lapham GT. Prevalence of medical cannabis use and associated health conditions documented in electronic health records among primary care patients in Washington state. JAMA Netw Open. 2021 May 3;4(5):e219375. doi: 10.1001/jamanetworkopen.2021.9375. PubMed
Heffner JL, Watson NL, Dahne J, Croghan I, Kelly MM, McClure JB, Bars M, Thrul J, Meier E. Recognizing and preventing participant deception in online nicotine and tobacco research studies: suggested tactics and a call to action. Nicotine Tob Res. 2021 Apr 20:ntab077. doi: 10.1093/ntr/ntab077. Online ahead of print. PubMed
Hser YI, Ober AJ, Dopp AR, Lin C, Osterhage KP, Clingan SE, Mooney LJ, Curtis ME, Marsch LA, McLeman B, Hichborn E, Lester LS, Baldwin LM, Liu Y, Jacobs P, Saxon AJ. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? early experiences in the feasibility study phase of a national drug abuse treatment clinical trials network trial. Addict Sci Clin Pract. 2021;16(1):24. doi: 10.1186/s13722-021-00233-x. PubMed
Jennifer F. Bobb, PhDAssociate Biostatistics Investigator |
Katharine A. Bradley, MD, MPHSenior Investigator |
Joseph E. Glass, PhD, MSWAssociate Investigator |
Clarissa Hsu, PhDAssociate Investigator |
Gwen Lapham, PhD, MPH, MSWAssistant Investigator |
Jennifer B. McClure, PhDDirector, Investigative Science |
Julie E. Richards, PhD, MPHAssistant Investigator |
Paige D. Wartko, PhD, MPHSenior Collaborative Scientist |
Yu-Ru Su, PhDAssociate Biostatistics Investigator |
Leah K. Hamilton, PhDSenior Collaborative Scientist |
Noorie Hyun, PhDAssociate Biostatistics Investigator |
Jess Mogk, MPHCollaborative Scientist |
Morgan Justice, MACollaborative Scientist |
Theresa E. Matson, PhD, MPHCollaborative Scientist |
Kevin Hallgren, PhD
Associate Professor
Department of Psychiatry and Behavioral Sciences
University of Washington
Emily Williams, PhD, MPH
Investigator
Health Services Research & Development
VA Puget Sound Health Care System
Edwin Wong, PhD
Associate Professor
Department of Health Services and Population Health
University of Washington